Literature DB >> 4051554

Production of acid and neutral cysteine-proteinase inhibitors by a cultured human skin epithelium cell line.

V K Hopsu-Havu, I Joronen, A Rinne, M Järvinen.   

Abstract

Human skin epithelial-like cells (NCTC-strain 2544) were grown in RPMI-1640 medium supplemented with foetal calf serum for up to 2 weeks. The culture medium and extracts made from the cells were subjected to gel-filtration chromatography in a Sephacryl S-200 column for fractionation of the proteins. The fractions were assayed for acid and neutral cysteine-proteinase inhibitor (ACPI, NCPI) using time-resolved fluoroimmunoassay and radioimmunoassay, and the cysteine-proteinase-inhibiting activities were assayed using papain. Free NCPI, i.e. a molecule with isoelectric variants at pHs 6.0 and 6.5, which has an Mr of around 12,000 and is capable of inhibiting papain, was detected both in the culture medium and in the cells. Immunodiffusion studies revealed its immunological identity with human spleen-derived NCPI. The amount of NCPI increased during the incubation period. ACPI--characterized as a molecule having an isoelectric point of 4.9, an Mr of about 12,000, papain-inhibiting capacity and antigenic reactivity with spleen-derived ACPI--was not detected in the culture medium. It was, however, detected in the cells after 2 weeks in culture. These data prove that ACPI and NCPI are synthesized by the NCTC-2544 cells under the present culture conditions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4051554     DOI: 10.1007/BF00510062

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  18 in total

1.  alpha-N-benzoylarginine-2-naphthylamide hydrolase (cathepsin B1 ?) from rat skin. II. Purification of the enzyme and demonstration of two inhibitors in the skin.

Authors:  M Järvinen; V K Hopsu-Havu
Journal:  Acta Chem Scand B       Date:  1975

2.  Separation of cysteine proteinase inhibitors from psoriatic scale.

Authors:  V K Hopsu-Havu; M Järvinen; A Rinne
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

3.  Cysteine proteinase inhibitors in psoriatic epidermis.

Authors:  V K Hopsu-Havu; I A Joronen; M Järvinen; A Rinne
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

4.  Epidermal cell production of thymocyte activating factor (ETAF).

Authors:  D N Sauder; C S Carter; S I Katz; J J Oppenheim
Journal:  J Invest Dermatol       Date:  1982-07       Impact factor: 8.551

5.  Time-resolved fluoroimmunoassay of human choriogonadotropin.

Authors:  K Pettersson; H Siitari; I Hemmilä; E Soini; T Lövgren; V Hänninen; P Tanner; U H Stenman
Journal:  Clin Chem       Date:  1983-01       Impact factor: 8.327

6.  Cysteine proteinase inhibitors produced by mononuclear phagocytes.

Authors:  V K Hopsu-Havu; I A Joronen; M Järvinen; A Rinne; M Aalto
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

7.  Characterization of a human epithelial cell line with special reference to its ultrastructure.

Authors:  K Ree; A S Johnsen; H E Rugstad; A Bakka; T Hovig
Journal:  Acta Pathol Microbiol Scand A       Date:  1981-03

8.  Purification and properties of two protease inhibitors from rat skin inhibiting papain and other SH-proteases.

Authors:  M Järvinen
Journal:  Acta Chem Scand B       Date:  1976

9.  Cerebrocystatin suppresses degradation of myelin basic protein by purified brain cysteine proteinase.

Authors:  M Kopitar; F Stern; N Marks
Journal:  Biochem Biophys Res Commun       Date:  1983-05-16       Impact factor: 3.575

10.  Human spleen cysteineproteinase inhibitor. Purification, fractionation into isoelectric variants and some properties of the variants.

Authors:  M Järvinen; A Rinne
Journal:  Biochim Biophys Acta       Date:  1982-11-09
View more
  3 in total

1.  A 43-kDa papain inhibitor produced by a cultured human epidermal cell line.

Authors:  V K Hopsu-Havu; I Joronen; A Rinne; M Järvinen
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

2.  Clinical relevance of cathepsin B-like enzyme activity and cysteine proteinase inhibitor in melanocytic tumours.

Authors:  A Yoshii; T Kageshita; H Tsushima; T Ono
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

3.  Separation and partial characterization of four cysteine proteinases from a human epidermal cell line.

Authors:  I A Joronen; V K Hopsu-Havu
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.